Valerio Therapeutics Société anonyme (LON:0NWK)

LON:0NWK Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.18	6.82	14.59	17.89	14.52
Cash & Short-Term Investments	1.18	6.82	14.59	17.89	14.52
Cash Growth	-82.72%	-53.26%	-18.45%	23.16%	154.43%
Accounts Receivable	1.72	1.89	1.47	8.53	6.65
Other Receivables	1.67	2.99	3.78	2.27	1.6
Receivables	3.39	4.88	5.25	10.8	8.25
Prepaid Expenses	-	1.17	0.29	1.45	0.4
Other Current Assets	-	0.13	0.45	-0	-
Total Current Assets	4.57	13	20.58	30.13	23.18
Property, Plant & Equipment	1.17	1.53	1.89	2.24	2.56
Goodwill	11.97	18.06	18.06	18.06	18.06
Other Intangible Assets	-3.26	-	-	-	0
Long-Term Deferred Charges	3.26	2.47	2.47	2.47	2.47
Other Long-Term Assets	0.22	0.22	0.09	0.16	0.23
Total Assets	17.93	35.27	43.09	53.06	46.51
Accounts Payable	5.25	2.46	3.45	2.83	2.76
Accrued Expenses	1.71	2.62	1.81	0.59	0.81
Short-Term Debt	3.13	2	0.05	-	-
Current Portion of Long-Term Debt	7.3	1.45	1	2.95	1.5
Current Portion of Leases	0.33	0.33	0.34	0.47	0.48
Current Income Taxes Payable	0.63	0.58	0.48	0.21	0.47
Other Current Liabilities	-	1.69	0.02	-	0.02
Total Current Liabilities	18.34	11.13	7.15	7.06	6.05
Long-Term Debt	5.63	6.91	8.1	5.08	2.5
Long-Term Leases	0.18	0.31	0.65	1.43	1.78
Long-Term Deferred Tax Liabilities	-	-	-	0.2	0.42
Other Long-Term Liabilities	2.01	2.01	4.75	5.74	6.12
Total Liabilities	26.19	20.47	20.82	20.12	17.47
Common Stock	21.61	38.59	27.88	23	19.58
Additional Paid-In Capital	15.69	28.99	27.71	24.58	18.58
Retained Earnings	-46.51	-53.14	-33.43	-5.94	1.09
Treasury Stock	-0.04	-0.06	-0.08	-0.18	-0.18
Comprehensive Income & Other	0.31	0.43	0.19	-8.52	-10.03
Total Common Equity	-8.93	14.81	22.27	32.94	29.04
Minority Interest	0.67	-	-	-	-
Shareholders' Equity	-8.27	14.81	22.27	32.94	29.04
Total Liabilities & Equity	17.93	35.27	43.09	53.06	46.51
Total Debt	16.56	11	10.13	9.93	6.26
Net Cash (Debt)	-15.38	-4.18	4.45	7.95	8.27
Net Cash Growth	-	-	-44.02%	-3.79%	-
Net Cash Per Share	-0.10	-0.03	0.04	0.09	0.11
Filing Date Shares Outstanding	153.88	154	110.93	111.08	78.05
Total Common Shares Outstanding	153.88	154	110.93	91.57	78.05
Working Capital	-13.77	1.87	13.43	23.07	17.13
Book Value Per Share	-0.06	0.10	0.20	0.36	0.37
Tangible Book Value	-17.64	-3.25	4.21	14.88	10.97
Tangible Book Value Per Share	-0.11	-0.02	0.04	0.16	0.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.